about
NMR structural analysis of alpha-bungarotoxin and its complex with the principal alpha-neurotoxin-binding sequence on the alpha 7 subunit of a neuronal nicotinic acetylcholine receptorMaking vaccines "on demand": a potential solution for emerging pathogens and biodefense?Universal H1N1 influenza vaccine development: identification of consensus class II hemagglutinin and neuraminidase epitopes derived from strains circulating between 1980 and 2011.Immunization with cross-conserved H1N1 influenza CD4+ T-cell epitopes lowers viral burden in HLA DR3 transgenic miceEpitope recognition in HLA-DR3 transgenic mice immunized to TSH-R protein or peptides.VaxCelerate II: rapid development of a self-assembling vaccine for Lassa fever.HelicoVax: epitope-based therapeutic Helicobacter pylori vaccination in a mouse modelVennVax, a DNA-prime, peptide-boost multi-T-cell epitope poxvirus vaccine, induces protective immunity against vaccinia infection by T cell response alone.Time for T? Immunoinformatics addresses vaccine design for neglected tropical and emerging infectious diseasesPrediction of immunogenicity for therapeutic proteins: state of the art.Progress towards a genome-derived, epitope-driven vaccine for latent TB infection.Tularemia vaccines - an overview.Epitope-based vaccination against pneumonic tularemiaIn vitro and in vivo studies of IgG-derived Treg epitopes (Tregitopes): a promising new tool for tolerance induction and treatment of autoimmunity.An immunoinformatics-derived DNA vaccine encoding human class II T cell epitopes of Ebola virus, Sudan virus, and Venezuelan equine encephalitis virus is immunogenic in HLA transgenic mice.Harnessing the power of genomics and immunoinformatics to produce improved vaccines.Smarter vaccine design will circumvent regulatory T cell-mediated evasion in chronic HIV and HCV infection.Of [Hamsters] and men: a new perspective on host cell proteins.A method for individualizing the prediction of immunogenicity of protein vaccines and biologic therapeutics: individualized T cell epitope measure (iTEM).Analysis of ChimeriVax Japanese Encephalitis Virus envelope for T-cell epitopes and comparison to circulating strain sequences.Putting immunoinformatics to the test.T-cell epitope content comparison (EpiCC) of swine H1 influenza A virus hemagglutinin.Immunoinformatic comparison of T-cell epitopes contained in novel swine-origin influenza A (H1N1) virus with epitopes in 2008-2009 conventional influenza vaccine.T cell epitope engineering: an avian H7N9 influenza vaccine strategy for pandemic preparedness and responseBuilding better biotherapeutics and vaccines by design: EpiVax, Inc., an immunology companyImmunoinformatic analysis of Chinese hamster ovary (CHO) protein contaminants in therapeutic protein formulationsTools for Vaccine Design: Prediction and Validation of Highly Immunogenic and Conserved Class II Epitopes and Development of Epitope-Driven VaccinesImmunoinformatic approach to a multi-pathogen genome-derived epitope-driven vaccineImmunoinformatic-drivenH. pylorivaccine designMycobacterium tuberculosisVaccine renaissance--from basic research to implementationNew tools, new approaches and new ideas for vaccine developmentPromiscuous CD4 Epitope Clusters Associated With Human Recall Responses Are Candidates for a Novel T-Cell Targeted Multi-Epitope Q Fever Vaccine
P50
Q27637297-5763DBA1-C474-4472-B137-CEB91BC3BFC8Q30222126-46921164-02BE-4392-B45A-C7308505A986Q30352021-A24A0AD4-A409-41F8-8A48-F23B5355B000Q30353698-3E5C56FE-08B0-4F0A-B702-8E396D851F1EQ33569672-EBE96EA5-0052-4394-94DD-CEF0A55E5BDAQ33723534-45F239C5-340F-4673-A9EA-1210AE9E7294Q34612386-1DCAA6B9-7E6A-441C-AD39-37A6EF2B71ABQ35089019-15AD0510-C128-43EF-8F31-056AD824D413Q36550981-20B30826-E044-4FD1-9F18-EA69AF770AD8Q36842569-270D1F26-AB1E-44DB-8D7F-BBC9A400BDE7Q37003740-D1711DAE-F4B7-4222-BB08-4260515F5E45Q37003754-5F4AE173-5CFB-43E3-A30C-A66CDB52EE07Q37409665-4A61644B-3B69-4317-8942-EB162A960639Q38039963-200F19CC-90F5-4A05-B8EF-0F808B1EC5B8Q40054259-84203409-3B3A-4469-A114-BF2C0F4B0452Q40162376-7BE4AF5C-349A-4C3C-A385-33D8948F4CFCQ41690948-070F7110-61DB-476F-B2CF-A3B9CD6ACBD8Q41870889-82BB4317-7B89-4DA8-A2D0-6ABB6DAFB546Q41939834-EFC73E29-C89C-439A-A884-EFC29EBB70CBQ43041486-3DE6E1E9-6B1F-4888-8776-2B1A4056637CQ44666159-FF8B98CF-7316-4D5D-9887-926D4E314680Q45325937-74C51319-3B85-4529-8DC4-B799EC707840Q45382232-86EDC708-9154-49DA-86F6-391338686121Q56786624-45149D3D-1575-4DE2-8218-E41A0643E662Q57537520-AC154CD5-D6CD-4F6E-969F-42E499770A66Q57537550-EC00B693-0FFA-4B44-B0B5-CA1C24EEC41BQ57537566-0B81CF54-CEC1-4D4E-B098-482B7AA59C86Q57537575-6665C401-5AF8-4DCE-AF9A-0CF1B8C5B062Q57537577-A365D6D7-4992-46B3-8928-759F637E0B18Q57537598-6BB377AE-AA27-433B-B0A7-42DE9789B83EQ57537630-67D93D74-82B8-478D-8286-AA1A4CCE001AQ57537644-3C91636B-CD07-4076-B9AA-9F416B7B87DFQ64266471-DEB7E33F-0AD8-469D-9A4E-B135DF27A87C
P50
name
Leonard Moise
@en
type
label
Leonard Moise
@en
prefLabel
Leonard Moise
@en